← FDA Drug Approvals (Drugs@FDA)

METARAMINOL BITARTRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ABRAXIS PHARM · Approved 1972-09-22

Drug application

FDA Application #
ANDA080431
Application type
Abbreviated New Drug Application (Generic)
Brand name
METARAMINOL BITARTRATE
Generic name
Metaraminol Bitartrate
Active ingredients
METARAMINOL BITARTRATE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Discontinued
Sponsor
ABRAXIS PHARM
First approval
1972-09-22

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown